跳至主要内容
临床试验/NL-OMON53573
NL-OMON53573招募中4 期

Assessing long-term outcomes of dupixent treatment in patients with chronic rhinosinusitis with nasal polyposis - AROMA

Regeneron Pharmaceuticals, Inc.0 个研究点目标入组 39 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients >=18 years at initiation
  • 2. All patients who are newly initiated on DUPIXENT for the treatment of CRSwNP
  • according to the respective prescribing information (Product Label or SmPC)
  • 3. Willing and able to comply with clinic visits and study-related procedures
  • as per protocol
  • 4. Provide informed consent signed by study patient or legally acceptable
  • representative
  • 5. Able to understand and complete study-related questionnaires as per protocol

排除标准

  • 1. Patients who have a contraindication to DUPIXENT according to the country
  • specific prescribing information
  • 2. Any previous treatment with DUPIXENT for any condition
  • 3. Any condition that, in the opinion of the investigator, may interfere with
  • the patient*s ability to participate in the study, such as short life
  • expectancy, substance abuse, severe cognitive impairment, or other medical,
  • social, or personal conditions and circumstances that can predictably prevent
  • the patient from adequately completing the schedule of visits and assessments
  • 4. Participation in an ongoing interventional or observational study that
  • might, in the treating physician*s opinion, influence the assessments for the
  • current study*

研究者

相似试验